Plain-English translation of NCT06347536 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a simple idea: when people with chronic obstructive pulmonary disease (COPD) leave the hospital after a flare-up, can we prevent them from getting worse by giving them a 'rescue pack' with prednisolone and antibiotics ready to use at home, along with twice-weekly automated reminder phone calls over 3 months? The study wants to see if this extra support and preparation helps patients stay healthier and out of the hospital.
Many people with COPD end up back in the hospital within a few months of leaving. Early treatment of a flare-up with the right medications can prevent hospital readmission, but patients often don't have the medications ready or don't recognize they need help soon enough. This trial is testing whether providing this medication in advance and keeping patients connected with regular reminders can catch problems early.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly placed into one of two groups. If you're in the main group, you'll receive a pack of rescue medications to keep at home, a written action plan, and automated phone calls twice a week for 3 months that ask about your breathing and symptoms. If you use your rescue pack during those 3 months, the study will send you a replacement. The comparison group will receive standard care without these extra supports. Either way, researchers will track whether you end up back in the hospital.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United Kingdom